Cargando…
A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286
Pharmacological GSK-3 inhibitors are potential drugs for the treatment of neurodegenerative diseases, cancer and diabetes. We examined the antiproliferative effects of two GSK-3 inhibitors, lithium and SB-415286, on B65 neuroblastoma cell line. Treatment of B65 cells with either drug administered se...
Autores principales: | Pizarro, Javier G, Folch, Jaume, Esparza, José Luis, Jordan, J, Pallàs, Mercè, Camins, Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516538/ https://www.ncbi.nlm.nih.gov/pubmed/18624766 http://dx.doi.org/10.1111/j.1582-4934.2008.00389.x |
Ejemplares similares
-
Experimental Models for Aging and their Potential for Novel Drug Discovery
por: Folch, Jaume, et al.
Publicado: (2018) -
Testing Fmr1(KO) Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127
por: Westmark, Pamela R., et al.
Publicado: (2021) -
Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways
por: Ettcheto, Miren, et al.
Publicado: (2017) -
SIRT1 and AROS suppress doxorubicin-induced apoptosis via inhibition of GSK3β activity in neuroblastoma cells
por: Kim, Jeong Woo, et al.
Publicado: (2020) -
Yokukansan enhances the proliferation of B65 neuroblastoma
por: Nakatani, Yoshihiko, et al.
Publicado: (2016)